Patient-derived xenograft (PDX) models, applications and challenges in cancer research

S Abdolahi, Z Ghazvinian, S Muhammadnejad… - Journal of Translational …, 2022 - Springer
The establishing of the first cancer models created a new perspective on the identification
and evaluation of new anti-cancer therapies in preclinical studies. Patient-derived xenograft …

Human organoids: tools for understanding biology and treating diseases

F Schutgens, H Clevers - Annual Review of Pathology …, 2020 - annualreviews.org
Organoids are in vitro–cultured three-dimensional structures that recapitulate key aspects of
in vivo organs. They can be established from pluripotent stem cells and from adult stem …

[HTML][HTML] Lung cancers: molecular characterization, clonal heterogeneity and evolution, and cancer stem cells

U Testa, G Castelli, E Pelosi - Cancers, 2018 - mdpi.com
Lung cancer causes the largest number of cancer-related deaths in the world. Most (85%) of
lung cancers are classified as non-small-cell lung cancer (NSCLC) and small-cell lung …

Organoid cultures as preclinical models of non–small cell lung cancer

R Shi, N Radulovich, C Ng, N Liu… - Clinical Cancer …, 2020 - aacrjournals.org
Purpose: Non–small cell lung cancer (NSCLC) is the most common cause of cancer-related
deaths worldwide. There is an unmet need to develop novel clinically relevant models of …

Patient-derived tumour xenografts as models for oncology drug development

JJ Tentler, AC Tan, CD Weekes, A Jimeno… - Nature reviews Clinical …, 2012 - nature.com
Progress in oncology drug development has been hampered by a lack of preclinical models
that reliably predict clinical activity of novel compounds in cancer patients. In an effort to …

Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models

RE Hynds, A Huebner, DR Pearce, MS Hill… - Nature …, 2024 - nature.com
Patient-derived xenograft (PDX) models are widely used in cancer research. To investigate
the genomic fidelity of non-small cell lung cancer PDX models, we established 48 PDX …

Organoid cultures for the analysis of cancer phenotypes

N Sachs, H Clevers - Current opinion in genetics & development, 2014 - Elsevier
Preclinical models of cancer are essential for a basic understanding of cancer biology and
its translation into efficient treatment options for affected patients. Cancer cell lines and …

One mouse, one patient paradigm: New avatars of personalized cancer therapy

P Malaney, SV Nicosia, V Davé - Cancer letters, 2014 - Elsevier
Over the last few decades, study of cancer in mouse models has gained popularity.
Sophisticated genetic manipulation technologies and commercialization of these murine …

c-MET as a potential therapeutic target and biomarker in cancer

JR Sierra, MS Tsao - Therapeutic advances in medical …, 2011 - journals.sagepub.com
The receptor tyrosine kinase c-MET and its ligand, hepatocyte growth factor (HGF), regulate
multiple cellular processes that stimulate cell proliferation, invasion and angiogenesis. This …

Organoid based personalized medicine: from bench to bedside

Y Li, P Tang, S Cai, J Peng, G Hua - Cell Regeneration, 2020 - Springer
Three-dimensional cultured organoids have become a powerful in vitro research tool that
preserves genetic, phenotypic and behavioral trait of in vivo organs, which can be …